Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system - First steps towards gene therapy of Alport syndrome

Gene Therapy

Volumn 3, Issue 1, 1996, Pages 21-27

  Heikkila P ^a   Parpala, T ^a   Lukkarinen, O ^a   Weber, M ^b   Tryggvason, K ^a,c  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alport syndrome; basement membrane; gene therapy; kidney glomeruli; organ perfusion

Indexed keywords

ADENOVIRUS; ALPORT SYNDROME; ARTICLE; BASEMENT MEMBRANE; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GLOMERULUS; HUMAN; HUMAN CELL; KIDNEY PERFUSION; MESANGIUM CELL; PRIORITY JOURNAL; REPORTER GENE;

ADENOVIRUSES, HUMAN; ANIMALS; BETA-GALACTOSIDASE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GLOMERULAR MESANGIUM; HUMANS; INFUSIONS, INTRA-ARTERIAL; KIDNEY; KIDNEY GLOMERULUS; NEPHRITIS, HEREDITARY; PERFUSION; SWINE; TUMOR CELLS, CULTURED;

EID: 0029959895     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Knebelmann B, Antignac C, Gubler M-C, Grünfeld JP. A molecular approach to inherited kidney disorders. Kidney Int 1993; 44: 1205-1216.
2. Gregory MC, Atkin CL. Alport syndrome. In: Schrier RW, Gottschalk CW (eds). Diseases of the Kidney, 5th edn. Little Brown: Boston, 1993, pp 571-592.
3. Koseki C, Herzlinger D, Al-Awqati Q. Integration of embryonic nephrogenic cells carrying a reporter gene into functioning nephrons. Am J Physiol 1991; 261: C550-C554.
4. Tomita N et al. Direct in vivo gene introduction into rat kidney. Biochem Biophys Res Commun 1992; 186: 129-134.
5. Isaka T, Fujiwara Y, Ueda N et al. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J Clin Invest 1993; 92: 2597-2601.
6. Moullier P et al. Adenoviral-mediated gene transfer to renal tubular cells in vivo. Kidney Int 1994; 45: 1220-1225.
7. Tryggvason K, Zhou J, Hostikka SL, Shows T. Molecular genetics of Alport syndrome. Kidney Int 1993; 43: 38-44.
8. Barker D et al. Identification of mutation on the COL4A5 collagen gene in Alport syndrome. Science 1990; 248: 1224-1227.
9. Hostikka SL et al. Identification of a distinct type IV collagen α chain with restricted kidney distribution and assignment of the gene to the locus of X chromosome-linked Alport syndrome. Proc Natl Acad Sci USA 1990; 87: 1606-1610.
10. Antignac C et al. Alport syndrome and diffuse leiomyomatosis: deletions in the 5′ end of the COL4A5 collagen genes. Kidney Int 1992; 42: 1178-1183.
11. Zhou J et al. Deletion of the paired alpha 5(IV) and alpha 6(IV) collagen genes in inherited smooth muscle tumors. Science 1993; 261: 1167-1169.
12. Mochizuki T et al. Identification of mutations in the α3(IV) and α4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 1994; 8: 77-82.
13. Butkowski RJ et al. Basement membrane collagen in the kidney: regional localization of novel chains related to collagen IV. Kidney Int 1989; 35: 1195-1202.
14. Hudson BG, Reeders ST, Tryggvason K. Type IV collagen: structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndrome and diffuse leiomyomatosis. J Biol Chem 1993; 268: 26033-26036.
15. Miner JH, Sanes RJ. Collagen IV α3, α4 and α5 chains in rodent basal laminae: sequence, distribution, association with laminins, and developmental switches. J Cell Biol 1994; 127: 879-891.
16. Kozarsky KF, Wilson JM. Gene therapy: adenovirus vectors. Curr Opin Genet Dev 1993; 3: 499-503.
17. Leinonen A et al. Complete primary structure of the human type IV collagen α4(IV) chain: comparison with structure and expression of the other α(IV) chains. J Biol Chem 1994; 269: 26172-26177.
18. Mariyama M et al. Complete primary structure of the human α3(IV) collagen chain: coexpression of the α3(IV) and α4(IV) collagen chains in human tissues. J Biol Chem 1994; 269: 23013-23017.
19. Hudson BG et al. The pathogenesis of Alport syndrome involves type IV collagen molecules containing the α3(IV) chain: evidence from anti-glomerular basement membrane nephritis after renal transplantation. Kidney Int 1992; 42: 179-187.
20. Engelhardt JF et al. Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1 deleted adenovirus. Nat Genet 1993; 4: 27-34.
21. Hurwitz DR, Chinnadurai G. Evidence that a second tumor antigen coded by adenovirus early gene region E1a is required for efficient cell transformation. Proc Natl Acad Sci USA 1985; 82: 163-167.
22. Holthöfer H, Sainio K, Miettinen A. Rat glomerular cells do not express podocytic markers when cultured in vitro. Lab Invest 1991; 65: 548-557.
23. Misra RP. Isolation of glomeruli from mammalian kidneys by graded sieving. Am J Clin Pathol 1972; 58: 135-139.
24. Tryggvason K, Kouvalainen K. Number of nephrons in normal human kidneys and kidneys of patients with the congenital nephrotic syndrome. Nephron 1975; 15: 62-68.
25. Parpala T, Lukkarinen O, Heikkilä P, Tryggvason K. A novel surgical organ perfusion method for effective ex vivo and in vivo gene transfer into renal glomerular cells. J Urol 1995; (submitted).
26. Hamilton RL et al. Inexpensive membrane lung for small organ perfusion. J Lipid Res 1974; 15: 182-186.